R6G9 Treatment Improves Viral-Induced Neurological Disease
- 技術應用
- This antibody may offer an attractive method for reducing CNS inflammation in humans and treating inflammatory demyelinating diseases such as MS.
- 詳細技術說明
- Researchers at the University of California, Irvine have identified a monoclonal antibody-based method that decreases immune cell infiltration into the CNS and improves neurological function in a mouse model of MS.
- *Abstract
-
Multiple Sclerosis (MS) is a devastating neurological disease. MS patients often experience neurologic dysfunction believed to be the result of infiltration of immune cells, inflammation of the central nervous system and eventual nerve damage.
- *Principal Investigation
-
Name: Thomas Lane
Department:
- 其他
-
Tech ID/UC Case
18869/2003-266-0
Related Cases
2003-266-0
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
